Pioneering Clinical-Grade Skin Science
HANSA GLOBAL Co., Ltd. is a South Korean biotechnology company dedicated to advancing regenerative aesthetics. We combine cutting-edge PDRN research with pharmaceutical-grade manufacturing to deliver solutions that aesthetic professionals can trust — and patients can feel.
Our Core Values
Clinical Integrity
Every formulation is backed by peer-reviewed science and validated through rigorous clinical testing before it reaches a professional's hands.
Precision Manufacturing
Our facility operates under ISO 22716 GMP standards, ensuring batch-to-batch consistency and sterility in every syringe.
Biocompatibility First
We engineer for safety. Our salmon-derived PDRN is processed to eliminate immunogenic risk, making it suitable for all skin types.
Professional Partnership
We work exclusively with licensed aesthetic professionals, providing clinical training, protocol support, and ongoing education.
Key Milestones
- 2018
HANSA GLOBAL Co., Ltd. founded in Incheon, Republic of Korea.
- 2020
ISO 22716 GMP certification achieved for cosmetic manufacturing.
- 2022
PDRN extraction process patented; first clinical trials completed.
- 2024
KFDA approval granted for HANSA Celluxe PDRN Skin Booster.
- 2026
International distribution launched across 12 countries.